WaveMan
WaveMan · Form 4
Williams Timothy insider trades
> Search tickers & screens ⌘K
LIVE

Williams Timothy insider trades

Williams Timothy has filed 14 Form 4s with the SEC that we hold, for Vanda Pharmaceuticals Inc. (VNDA) (SVP & General Counsel) and Geron Corp (GERN) (EVP and Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 11 sales worth $959.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($350.9K). The largest single trade was a sale of 42,434 shares of Vanda Pharmaceuticals Inc. worth $350.9K, dated 2026-03-02. The first filing on our record is dated 2021-08-17 and the latest 2026-04-14.

Vanda Pharmaceuticals Inc. (VNDA)

SVP & General Counsel · 13 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiledSource
2021-08-16S, sale reported on Form 43,715$60.0K2021-08-17SEC
2022-03-02S, sale reported on Form 412,060$133.7K2022-03-02SEC
2022-08-15S, sale reported on Form 43,689$38.4K2022-08-17SEC
2022-08-15S, sale reported on Form 44,611$47.1K2022-08-17SEC
2022-12-15S, sale reported on Form 48,000$56.1K2022-12-16SEC
2023-03-02S, sale reported on Form 48,437$52.6K2023-03-06SEC
2023-03-03S, sale reported on Form 48,301$51.9K2023-03-06SEC
2023-06-13S, sale reported on Form 414,600$95.8K2023-06-15SEC
2024-03-04S, sale reported on Form 48,147$35.9K2024-03-06SEC
2024-03-05S, sale reported on Form 48,941$37.4K2024-03-06SEC
2026-03-02S, sale reported on Form 442,434$350.9K2026-03-04SEC

Geron Corp (GERN)

EVP and Chief Legal Officer · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1748392) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms